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Summary
 
Nip3 (nineteen kD interacting protein-3) is an E1B 19K and Bcl-2 binding protein of un-
known function. Nip3 is detected as both a 60- and 30-kD protein in vivo and in vitro and ex-
hibits strong homologous interaction in a yeast two-hybrid system indicating that it can ho-
modimerize. Nip3 is expressed in mitochondria and a mutant (Nip3
 
163
 
) lacking the putative
transmembrane domain and COOH terminus does not dimerize or localize to mitochondria.
Transient transfection of epitope-tagged Nip3 in Rat-1 fibroblasts and MCF-7 breast carci-
noma induces apoptosis within 12 h while cells transfected with the Nip3
 
163
 
 mutant have a
normal phenotype, suggesting that mitochondrial localization is necessary for induction of cell
death. Nip3 overexpression increases the sensitivity to apoptosis induced by granzyme B and
topoisomerase I and II inhibitors. After transfection, both Nip3 and Nip3
 
163
 
 protein levels de-
crease steadily over 48 h indicating that the protein is rapidly degraded and this occurs in the
absence of cell death. Bcl-2 overexpression initially delays the onset of apoptosis induced by
Nip3 but the resistance is completely overcome in longer periods of incubation. Nip3 protein
levels are much higher and persist longer in Bcl-2 expressing cells. In conclusion, Nip3 is an
apoptosis-inducing dimeric mitochondrial protein that can overcome Bcl-2 suppression.
 
T
 
he genetic regulation of cell death is thought to be a
central mechanism of cellular homeostasis and devel-
opment (1–4). The Bcl-2 family of genes (1, 5), which are
related to 
 
ced-9
 
 of 
 
Caenorhabditis elegans
 
 (6), were originally
identified as repressors of cell death. It is known that both
pro- and anti- apoptotic Bcl-2 homologues exist, however
their exact biochemical function has not been determined.
Recent studies suggests that Ced-9 and Bcl-2/Bcl-X
 
L
 
 may
physically interact with proteins that are required for the
execution of apoptosis, Ced-3 and Ced-4 (7–9). Ced-3 is a
protease which in mammals is represented by a large family
of cysteine proteases which cleave after aspartic acid, now
called caspases (4, 10). In mammalian cells overexpression
of 
 
bcl-2
 
 prevents the processing and activation of caspase-3
(CPP32) (11, 12).
Bcl-2 family members bear COOH-terminal transmem-
brane domains that allow their association with the outer
mitochondrial membrane (13) and this mitochondrial lo-
calization is important for the suppressive function of Bcl-2
(14, 15). There is growing evidence that mitochondrial func-
tion is disturbed early in the apoptotic response and may be
important in mediating apoptosis (16–18). This is often seen
as the loss of mitochondrial membrane potential (16, 17)
and the release of cytochrome c (18), and cytochrome c has
been implicated in the activation of caspases (18–20). Bcl-2
can suppress the release of cytochrome c from mitochon-
dria and prevent caspase activation (19, 20).
The adenovirus E1B 19K protein is functionally similar
to Bcl-2 as a survival factor (1). A two hybrid screen of
proteins that interact with E1B 19K in the yeast 
 
Saccharomy-
ces cerevisiae
 
 identified several unique cDNAs named Nip1,
Nip2, and Nip3 (21). All three proteins interact with dis-
crete conserved domains of E1B 19K protein and Bcl-2 that
are involved in suppression of cell death, although a func-
tion was not identified. We report here that Nip3 is a pro-
apoptotic mitochondrial protein that both induces apopto-
sis and increases the sensitivity of cells to apoptosis induced
by drugs and granzyme B. Nip3 can overcome Bcl-2 sup-
pression and may be related to pro-apoptotic members of
the Bcl-2 family.
 
Materials and Methods
 
Cell Cultures and Reagents.
 
Rat-1, Rat-1/Bcl-2, and MCF-7
cells used in this study were cultured in 
 
a
 
-minimal essential me-
  
1976
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dium (
 
a
 
-MEM)
 
1
 
; (GIBCO BRL, Gaithersburg, MD) supple-
mented  with 10% fetal bovine serum (GIBCO). Murine mono-
clonal anti-HA 12CA5 and anti-T7 antibody were purchased
from Boehringer Mannheim (Laval, Quebec) and Novagen (Madi-
son, WI), respectively. Rabbit anti-HSP60 antibody was donated by
Dr. Radhey Gupta (McMaster University, Hamilton, Ontario).
FITC-conjugated goat anti–rabbit IgG (FITC; Sigma Chem. Co.,
St. Louis, MO) and Cy3-conjugated goat anti–mouse IgG (Bio-
Can Ltd., Mississauga, Ontario) were used for fluorescence studies.
 
Cloning and Construction of Expression Plasmids.
 
After isolation
of a Nip3 cDNA, we utilized RACE to identify both 3
 
9
 
 and 5
 
9
 
ends using a premade human brain marathon-ready cDNA ac-
cording to the manufacturer’s instructions (Clontech, Palo Alto,
CA). The Nip3 3
 
9
 
 RACE was done using primer 5
 
9
 
CAG-
CGTTCCAGCCTCGGTTTCT3
 
9
 
 while the 5
 
9
 
 RACE was
done using three different primers 5
 
9
 
CAAAGGTGCTGGTGG-
AGGT3
 
9
 
, 5
 
9
 
TGTGGTGTCTGCGAGCGAGGT3
 
9
 
, and 5
 
9
 
TCC-
AGCAGTATTTTTTCCA3
 
9
 
. The appropriate RACE products
were TA cloned (Invitrogen, San Diego, CA) and several of the
resulting clones were analysed to obtain the described Nip3 se-
quence.
To construct epitope tagged Nip3 in expression plasmids, KpnI
and EcoRI sites were introduced to the 5
 
9
 
 and 3
 
9
 
 end of the Nip3
cDNA encoding only the open reading frame by PCR amplifica-
tion and its sequence was confirmed by the T7 sequencing Kit
(Pharmacia LKB Biotechnology, Inc., Piscataway, NJ), then in-
serted in frame into the KpnI-BamHI sites of plasmid pKM1310
containing the 5
 
9
 
 HA-tag. The recombinant cDNA 5
 
9
 
HA-Nip3
was then isolated by EcoRI digestion and blunt end ligated into
the plasmid pKG86 creating the plasmid pKG5HA-Nip3 under
the control of SP6 promoter which was used for in vitro transcrip-
tion/translation of 5
 
9
 
HA-tagged Nip3 proteins. The plasmid
pKG5HA-Nip3
 
163
 
 was generated by PCR and constructed as de-
scribed above.
For cloning the Nip3 cDNA into the expression vector pcDNA3
(Invitrogen Corp.), the HindIII site was introduced at the 5
 
9
 
 end
of HA-Nip3 cDNA by PCR amplification then cloning into the
HindIII-EcoRI sites. The HindIII-KpnI fragment containing the
HA-tag was inserted into the HindIII-KpnI sites of pcDNA3
vector making the pcD-5HA vector for cloning the 5
 
9
 
HA-tagged
Nip3 cDNA and its mutants. For 5
 
9
 
HA-Nip3 and 5
 
9
 
HA-Nip3
 
163
 
,
the cDNA fragments were isolated by KpnI-EcoRI digestion of
pKG5HA-Nip3 and pKG5HA-Nip3
 
163
 
, respectively, then in-
serted into KpnI-EcoRI sites of pcD-5HA vector, making
pcD5HA-Nip3 and pcD5HA-Nip3
 
163
 
. For the 3
 
9
 
 T7 tagged
Nip3 and Nip3
 
163
 
, a cDNA fragment encoding the T7 epitope
was inserted into the EcoRI/XhoI sites of pcDNA3 plasmid. The
3
 
9
 
 T7-tagged Nip3 and Nip3
 
163
 
 open reading frame were cloned
into this vector as described above. These recombinant plasmids
were used for in vitro translation and transient transfection into
the mammalian cells.
For yeast transfection, plasmids encoding Nip3 and Nip3
 
163
 
with suitable restriction sites were generated by PCR then ligated
in-frame in the GAL4 binding domain of pAS1 or pGBT9 and
GAL4 transcriptional activating domain of pACTII. The nucle-
otide sequence of all constructs was confirmed on an ABI 310
Genetic Analyzer (Applied Biosystems, Foster City, CA). The pAS1
or pGBT9 and pACTII constructs were cotransformed into the
yeast strain KGY37 and colonies selected on SC medium lacking
leucine and tryptophan. Protein–protein interactions were deter-
mined by growth on SC medium lacking leucine, tryptophan and
histidine in the presence of 1 mM 3-amino-1,2,4-triazole (3AT).
The relative 
 
b
 
-galactosidase activity was measured using both the
filter lift (X-Gal) and ONGP methods according to manufac-
turer’s instructions.
 
In Vitro Translation.
 
35
 
S-labeled Nip3 protein and mutants
were prepared by in vitro transcription and translation of cDNA
cloned in pcD-3HA vector using TnT coupled Reticulocyte Ly-
sate System (Promega Corp., Madison, WI) according to manu-
facturer’s instructions.
 
Two-dimensional Peptide Mapping.
 
[
 
35
 
S]methionine-labeled in
vitro translated full-length Nip3 and Nip3
 
163
 
 proteins were im-
munoprecipitated using mouse monoclonal anti-Nip3 antibody.
The proteins were then recovered from unfixed dried SDS–poly-
acrylamide gels by homogenizing the gel slices, then precipitated
with trichloroacetic acid and oxidized with performic acid as de-
scribed previously (22). The oxidized proteins were then resus-
pended in 25 ml of 50 mM NH
 
4
 
HCO
 
3
 
 and digested overnight at
37
 
8
 
C with 10 mg TPCK-treated trypsin. An additional 5 mg of
trypsin was then added, and digestion continued for at least an-
other 4 h. After digestion, samples were repeatedly lyophilized (four
times) using a Speedvac concentrator. Tryptic digests of the me-
thionine-labeled Nip3 proteins were subjected to electrophoresis
using pH 1.9 buffer (15% acetic acid, 5% formic acid) followed by
ascending chromatography with Scheidtmann buffer (isobutyric
acid/pyridine/acetic acid/butanol/water (65:5:3:2:29) as described
previously (23). [
 
35
 
S]methionine-labeled peptides were visualized
by autoradiography.
 
Transient Transfection and Apoptosis Assays.
 
Rat-1 cells, Rat-
1/Bcl-2 or MCF-7 cells were transfected with Nip3 and mutants
in the expression plasmid pcDNA3 using LipofectAMINE Re-
agent (GIBCO BRL). Cells (3–8 
 
3
 
 10
 
5
 
) were plated onto 100 
 
3
 
20 mm tissue culture dishes (Nunc, Roskilde, Denmark) in 12 ml
of complete medium 24 h before transfection. The DNA-Lipo-
fectAMINE mixture was allowed to incubate in a tissue culture
incubator for 3 h for Rat-1 or 5 h for MCF-7 cells.
Aliquots of 5 
 
3
 
 10
 
5
 
 cells were Western blotted as described
previously using mouse monoclonal anti-HA antibody 12CA5 or
anti-T7 antibody using an ECL detection kit according to manu-
facturers instructions (Amersham, Amersham, UK). For some ex-
periments, cells were treated with granzyme B and perforin as pre-
viously described (24), etoposide or camptothecin, then stained
with anti-T7 antibody with FITC-conjugated rabbit anti–mouse
antibody and apoptotic cells were enumerated by altered DNA
morphology with Hoechst dye staining, counting between 200 and
300 cells per sample (24).
For subcellular localization, cells were grown on cover slips,
transfected with HA-Nip3 then fixed with 4% formaldehyde in
PBS. Cells were double stained with mouse monoclonal anti-HA
antibody 12CA5 and anti-HSP60 antibody and visualized with
FITC-conjugated goat anti–mouse IgG secondary antibody and
Cy3-conjugated goat anti–rabbit antibody. Fluorescence was vi-
sualized using a Zeiss Axiophot microscope equipped with a
cooled CCD camera driven by IPLabs Spectrum H-SU2 (version
3.0; Signal Analytics Corp., Vienna, VA) and Multiprobe 1.1 E
(Signal Analytics) software.
 
RNA Isolation and Northern Hybridization Analysis.
 
Total RNA
from mice tissues was kindly provided by Dr. Robert Shiu (Uni-
versity of Manitoba). For Northern blot analysis 30 
 
m
 
g of total
RNA was hybridized with nick-translated Nip3 probe (1–5 
 
3
 
10
 
8
 
 cpm 
 
m
 
g DNA) at 42
 
8
 
C for 16–20 h. After hybridization and
 
1
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a
 
-MEM, 
 
a
 
-minimal essential medium;
3AT, 3-amino-1,2,4-triazole. 
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washing blots were exposed to Kodak XAR film at 
 
2
 
70
 
8
 
C with
an intensifying screen.
 
Results
 
Ubiquitous Expression of Nip3.
 
We isolated several Nip3
cDNAs from a human EBV transformed peripheral B lym-
phocyte library (Clonetech) by PCR and RACE of both 5
 
9
 
and 3
 
9
 
 ends, and identified the longest as a 1,535-bp se-
quence (see Genebank accession number AF002697 for
complete sequence). This is similar to the cDNA identified
earlier (21) except in the 3
 
9
 
 UTR where we find no evi-
dence of a homologous calbindin region in several inde-
pendent experiments. The RNA has a long 3
 
9
 
 UTR and
shorter 5
 
9
 
 UTR, and the encoded protein contains 194
amino acids and has a predicted molecular mass of 
 
z
 
21.54
kD with a pI of 6.08. There is a putative transmembrane do-
main between amino acids 164 to 184 (Fig. 1 
 
A
 
). Nip3
mRNA is expressed in human breast carcinoma MCF-7 as
a major transcript of 
 
z
 
1.7 kb and two minor transcripts of
1.5 and 1.3 kb. The level of Nip3 mRNA in mouse tissues
was also examined to determine how widely the gene is ex-
pressed. Two transcripts of 2.5 and 1.7-kb were identified
with the 1.7-kb transcript found in all tissues examined and
the larger transcript only in certain tissues such as brain,
heart, kidney, liver, and submaxillary gland (Fig. 1 
 
B
 
). The
identification of more than one Nip3 transcript in human
and murine cells may indicate that the gene is alternately
spliced or another closely related gene exists.
 
Nip3 Protein Is Expressed as a Dimer and Monomer.
 
We pre-
pared [
 
35
 
S]methionine-labeled Nip3 by in vitro transcrip-
tion and translation and examined the protein on SDS-
PAGE. Nip3 was seen as a major band at 
 
z
 
60 kD and a
smaller band of 30 kD (Fig. 2 
 
A
 
). Nip3 has a predicted mo-
lecular mass of 
 
z
 
21.54 kD, much smaller than the size of
the two bands estimated from SDS-PAGE, indicating that
the protein runs anomalously. The two bands were seen
under both reducing and nonreducing conditions. How-
ever, when the COOH terminus from amino acid 163 was
removed (Nip3
 
163
 
) (Fig. 1 
 
A
 
), the large molecular mass form
was absent and a major band of 28 kD and a minor band of
27 kD were detected. These data suggest that the 30-kD
protein is a Nip3 monomer while the 60-kD protein is a
dimer that was formed by interaction at the COOH termi-
nus of the protein. To examine more directly if Nip3 is a
homodimer, we compared tryptic peptide fragments of the
60-kD Nip3 to the 28-kD Nip3
 
163
 
. After in vitro transla-
tion, [
 
35
 
S]methionine-labeled Nip3 and Nip3
 
163
 
 were puri-
fied by immunoprecipitation with mouse mAb to Nip3 and
SDS PAGE. Tryptic peptides were prepared and fragments
separated by 2D electrophoresis and chromatography and
detected by radioautography as described in Materials and
Methods. Three peptide fragments of Nip3 and Nip3
 
163
 
contain methionine, while the COOH-terminal fragments
including the truncated region of Nip3
 
163
 
 do not. Fig. 2 
 
B
 
illustrates that the two proteins have three major [
 
35
 
S]me-
thionine-labeled peptides and their positions are very simi-
lar after 2D mapping. No other major peptides are detected
in the 60-kD Nip3 band. Minor proteins are also similar
and likely represent partially digested Nip3.
The ability of Nip3 to homodimerize was next exam-
ined in the yeast two hybrid system by inserting the Nip3
Figure 1. (A) Nip3 mRNA of
1535 bp is shown with the open
reading frame boxed with the
predicted protein of 194 amino
acids. The putative transmem-
brane domain between amino
acids 164 and 184 of Nip3 pro-
tein is shaded. A mutant lacking
the transmembrane sequence was
constructed by truncation at
amino acid 163 and is called
Nip3163. (B) Nip3 Northern
blot of RNA extracted from
multiple murine tissues as indi-
cated, and human MCF-7 mam-
mary carcinoma cells. Transcript
sizes are noted on the right. 
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cDNA in the GAL4 binding and activating domains which
were then simultaneously expressed in yeast cells (KGY37).
This was compared to Nip3 interaction with non specific
protein controls. A strongly positive interaction was found
with Nip3 in both vectors indicating that the protein was
capable of binding to itself (Table 1). In contrast, the
Nip3163 was unable to interact with Nip3 or with itself
(Fig. 2 C) indicating that the COOH terminus was re-
quired for homodimerization.
Subcellular Localization of Nip3 to Mitochondria. Boyd et
al. (21) reported that HA-Nip3 localizes in discrete cyto-
plasmic patches which are typical of a mitochondrial distri-
bution. To confirm the mitochondrial localization of Nip3
and to test the hypothesis that it depends on the putative
transmembrane domain, we transfected Rat-1 cells with
HA-Nip3 or HA-Nip3163 then stained with FITC-conju-
gated anti-HA antibody. Cells were simultaneously treated
with anti-HSP60 antibody which primarily stains mitochon-
dria (15) and Cy3-conjugated second antibody. Both the
green Nip3 and red HSP60 fluorescence appeared in a sim-
ilar punctate pattern, and when the images were combined,
a uniform yellow staining pattern indicated virtually com-
plete coincidence of the two stains (Fig. 3, A–C). In con-
trast, HA-Nip3163 stained diffusely throughout the cytoplasm
rather than the punctate distribution of the intact Nip3,
however, a small amount of HA staining appeared to colo-
calize with HSP60 by double fluorescence (Fig. 3, D–F).
Overexpression of Nip3 but not Nip3163 Induces Apoptosis.
T7 epitope-tagged Nip3 was transiently expressed in Rat-1
or MCF-7 cells. Cells were stained with both anti-T7 anti-
body to identify cells expressing Nip3, and Hoechst dye to
quantitate apoptosis. Over time, progressively more Nip3 ex-
pressing cells became apoptotic starting around 12 h and
reaching completion by 48 to 60 h (Fig. 4 A). Nip3 protein
measured by anti-T7 Western blot were highest between
12 and 24 h after transfection then progressively decreased
with time paralleling the induction of apoptosis (Fig. 4 B).
To determine if the transmembrane domain of Nip3 which
is necessary for mitochondrial localization was also neces-
sary to induce apoptosis, the experiment was repeated using
the Nip3163. The mutant was unable to induce apoptosis
(Fig. 4, A and B). Of additional interest, Nip3163 protein
levels decreased very rapidly with time despite the inability
of the mutant to induce apoptosis, thus indicating that the
loss of protein in the cell lysates was not related to the
death of cells.
Nip3 Sensitizes Rat-1 Cells to Apoptosis. To determine
whether Nip3 can influence apoptosis induced by other
cell death signals, Rat-1 cells were transiently transfected
Figure 2. In vitro expression of Nip3 as a homodimer. (A) After in vitro transcription and translation of Nip3 the 35S-labeled protein was separated on
SDS-PAGE (lanes 1 and 2) under reducing (R, lane 1) and nonreducing (NR, lane 2) conditions. Nip3 runs as two bands at 60 and 30 kD. Nip3163 is a
truncated mutant in which the terminal 31 amino acids from 164 to 194 containing the putative transmembrane domain have been removed (lanes 3 and
4). The truncated Nip3163 is expressed as a major band at 29 kD and a minor band at 28 kD under both reducing (lane 3) and nonreducing (lane 4) con-
ditions. (B) Comparative peptide mapping of in vitro translated 35S-labeled 60-kD Nip3 and 28-kD Nip3163 protein. After in vitro translation, Nip3 and
Nip3163 were immunoprecipitated, the 60- and 28-kD bands recovered after SDS-PAGE then trypsin digested. The resulting peptides were separated on
the same plate by electrophoresis at pH 1.9 (horizontal dimension with anode to the left), followed by ascending chromatography. The positions of the
origin of Nip3 and Nip3163 are marked by arrows. Three [35S]methionine-labeled peptides predicted from the trypsin digest are circled and labeled A, B,
and C (Nip3) and A9, B9, and C9 (Nip3163). Peptide A and A9, amino acids 1–45; B and B9, amino acids 140–146; C and C9, 147–152. All three peptides
are represented in both Nip3 and Nip3163. Minor spots are similar in the two proteins and likely are partially digested fragments. One of two experiments
with similar results is shown. (C) Yeast two-hybrid system identifies Nip3 homodimerization. (left) Plasmids encoding full-length Nip3 and the COOH-
terminal truncated mutant Nip3163 fused to the GAL4 DNA-binding domain were cotransformed with plasmids encoding Nip3, Nip3163 or empty vector se-
quences fused to the GAL4 transcriptional activation domain. Protein–protein interactions were determined by growth of yeast in the absence of leucine,
tryptophan and histidine. (Right) Growth in the absence of leucine and tryptophan is shown as a control. The results are representative of 3 independent
experiments.
Table 1. Interaction of Nip3 in Yeast Two Hybrid System
Protein‡
Relative level 
of X-Gal
lacZ expression* 
ONPG
pAS1 W 0.7
Nip3 W 1.0
Nip3/Nip3 B 103.3
MK/Nip3 W 0.3
PTP2/Nip3 W 0.5
*Relative level of interaction is based on b-galactosidase activity. W,
white; B, blue.
‡Binding domain/Activating domain; pAS1, empty vector; MK, Myo-
tonin Kinase; PTP2, protein tyrosine phosphatase 2.1979 Chen et al.
with T7-Nip3 for 12 h then treated with increasing doses
of the cytotoxic lymphocyte protease granzyme B, or the
topoisomerase I and II inhibitors etoposide or camptothe-
cin. The 12-h transfection was chosen because of minimal
effects of Nip3 on cell survival at this time. Apoptotic cells
were then quantitated by Hoechst dye in cells either ex-
pressing or not expressing T7-Nip3 protein within the
same samples, using immunofluorescence staining by anti-
T7 antibody to detect Nip3. The frequency of apoptotic
cells was clearly higher in Nip3-expressing cells (Fig. 5). A
5–10-fold increase in sensitivity to the drugs and a 2–3-fold
increase in granzyme B apoptosis was observed in three in-
dependent experiments.
Nip3 Overcomes Bcl-2 Suppression of Apoptosis. Since it
Figure 3. Subcellular localization of Nip3 and Nip3163. Rat-1 cells were transfected with HA-Nip3 and stained with anti-HA antibody using FITC (A)
and the mitochondrial protein marker anti-HSP60 antibody using Cy3 (B). The stained images were combined to compare the staining pattern of both
proteins (C) and their coincidence is indicated by the conversion of green FITC and red Cy3 stain to yellow thoughout the cell cytoplasm. HA-Nip3163
was expressed in Rat-1 cells then stained with anti-HA antibody (D), or anti-HSP60 antibody (E) and shown as a combined image using antibodies (F),
as described above.1980 Mitochondrial Protein Nip3 Induces Apoptosis
had been demonstrated that Bcl-2 binds Nip3 (21), we
next determined if Bcl-2 was capable of suppressing Nip3-
induced apoptosis. Rat-1 and Rat-1/Bcl-2 cells (Fig. 6 C)
were transfected with T7-Nip3 and apoptotic cells appear-
ing in both populations was determined over time. Apo-
ptotic Rat-1 cells expressing Nip3 were detected within 12 h
and reached maximum levels by 48 h, while Nip3 did not
induce cell death in Rat-1/Bcl-2 cells until 24 h after trans-
fection. However, by 48 h virtually all cells expressing Nip3
were apoptotic despite Bcl-2 overexpression (Fig. 6 A). The
Rat-1 cells expressing Bcl-2 were highly resistant to gran-
zyme B and perforin (Fig. 6 A). We noticed that Nip3 pro-
tein level was considerably higher in Rat-1/Bcl-2 cells than
in Rat-1 cells by 12 h after transfection and remained higher
throughout the time course. However, a significant de-
crease in Nip3 level was detected by 48–60 h in Rat-1/
Bcl-2 cells at the same time that recovery of apoptosis was
detected (Fig. 6 B).
Discussion
In the present study we have identified the E1B 19-kD/
Bcl-2–binding protein Nip3 as a pro-apoptotic protein that
localizes to mitochondria. Nip3 protein is unusual in sev-
eral respects. It migrates on SDS-PAGE at a molecular mass
that is much higher than the 21.54-kD predicted by the
primary amino acid sequence and appears in vivo after
transfection and in vitro after transcription and translation
as 60- and 30-kD proteins. The 60-kD band does not dis-
sociate after reduction or reduction and alkylation, nor af-
ter treatment with 6M urea (Chen, G., and A.H. Green-
berg, unpublished data). Thus Nip3 appears to interact with a
second protein very strongly and the evidence favors ho-
modimerization. Three experiments support this conclusion.
First, truncation of the COOH-terminal 31 amino acids
results in the loss of the 60-kD Nip3 band and only a lower
molecular weight protein is observed. Second, [35S]methio-
nine-labeled tryptic peptide fragments of the 60-kD Nip3
were identical to the 28-kD Nip3163, and finally, Nip3 ex-
hibits strong interaction with itself in the yeast two hybrid
system. The inability to bind Nip3163 to interact with Nip3
or itself indicates that it cannot dimerize and is consistent
with the requirement of the COOH-terminal portion of
Nip3 for homodimerization.
The COOH-terminal domain of Nip3 not only influ-
ences dimer formation but also directs its expression to mi-
tochondria. Nip3 colocalized with HSP60 which is primarily
expressed in mitochondria (25) while the mutant Nip3163
Figure 4. Overexpression of Nip3 but not Nip3163 induces apoptosis.
(A) Rat-1 or MCF-7 (left) cells were transfected with T7-tagged Nip3 then
at different times cells harvested and stained with anti-T7 antibody and
FITC anti–mouse IgG antibody to identify cells expressing Nip3. The
frequency of apoptotic cells was quantitated by Hoechst dye staining.
Rat-1 cells (right) were then transfected and apoptotic cells expressing (d)
and not expressing (s) Nip3 were quantitated. Rat-1 cells expressing (.)
or not expressing (,) Nip3163 were analysed in the same manner. At least
200 cells were counted in each sample. All assays were repeated three to
seven times with identical results. (B) Western blot of Rat-1 cells trans-
fected with T7-Nip3 (left) or T7-Nip3163 (right). Cells were harvested at
the times indicated and Western blots developed with anti-T7 antibody.1981 Chen et al.
lacking the transmembrane domain was mostly expressed as
a free cytosolic protein. A minor component of the Nip3163
protein was colocalized with the mitochondrial markers sug-
gesting that it may interact by a mechanism other than
membrane insertion, perhaps by binding to other mitochon-
drial proteins. Nip3163 does not interact with Nip3 or form
a homodimer in vitro so it likely does not homodimerize
with endogenous Nip3 in vivo.
Nip3 protein expression progressively decreases over
time, which may reflect the increasing death of Nip3 ex-
pressing cells. Partial Bcl-2 suppression of Nip-3 induced
apoptosis and a significant increase in Nip3 protein levels
suggests that at least part of the Nip3 is lost by cell death.
However, a progressive decrease in protein levels was also
observed with the Nip3163 mutant which does not induce
apoptosis, therefore another mechanism is affecting protein
turnover. Nip3 contains PEST sequences suggesting that the
protein may be susceptible to rapid degradation by pro-
teases. PEST sequences commonly contain high local con-
centrations of amino acids P, E, S, T, and D flanked by
charged amino acids (26) and these are abundantly present
in Nip3. Thus the posttranslational control of Nip3 expres-
sion through rapid protein degradation may constitute a
mechanism for regulating the intracellular levels of a poten-
tially lethal protein.
Nip3 was originally identified as an E1B 19K interacting
protein, but the structure of Nip3 does not closely resem-
ble other death agonists of the Bcl-2 family. Bcl-2 family
agonists such as Bax act by heterodimerizing with anti-apo-
ptotic family members and mutations in BH1 and BH2 do-
Figure 5. Nip3 sensitizes Rat-1
cells to drug-induced apoptosis.
Rat-1 cells were transfected with
T7-tagged Nip3 then 12 h later
treated with increasing amounts
of etoposide, camptothecin or
granzyme B and perforin. Cells
expressing Nip3 were identified
by anti-T7 antibody and the nu-
cleus stained with Hoechst dye.
Apoptotic cells expressing Nip3
(Nip3 1) or cells not expressing
Nip3 (Nip3 2) were enumer-
ated. This is representative of
three experiments showing simi-
lar results.
Figure 6. Nip3 overcomes Bcl-2 suppression of apoptosis. (A) (Left)
Rat-1 and Rat-1/Bcl-2 cells were transfected with T7-Nip3 and at in-
creasing time the cells were harvested and Nip3-expressing apoptotic
cells quantitated as described in Fig. 4. (Right) The Rat-1 and Rat-1/
Bcl-2 cells were treated with granzyme B as shown at a constant con-
centration of perforin (125 ng/ml) for 3 h and apoptotic cells quanti-
tated by Hoechst dye as described previously (22). Three other experi-
ments showed similar results. (B) After transfection of Rat-1 and Rat-1/
Bcl-2 cells with T7-Nip3, lysates were harvested at increasing time in-
tervals then Western blotted with anti-T7 antibody. Molecular mass
markers are shown on the left. (C) Western blot of Bcl-2 (arrow) in
Rat-1 (lane 1) and Rat-1/Bcl-2 (lane 2) cell lines. Blots were devel-
oped with rabbit anti–human Bcl-2 (PharMingen). Relative molecular
mass (kD) is shown on the left.1982 Mitochondrial Protein Nip3 Induces Apoptosis
mains in Bcl-2 or Bcl-XL result in loss of binding and anti-
apoptotic activity (27, 28). However, other studies suggest
that pro- and anti-apoptotic Bcl-2 family members can act
independently (28) or through other family members such
as BAD (29, 30). Nip3 does not contain either a BH1 or BH2
domain, although it may have a BH3 domain in which
leucine110, aspartic acid115, and isoleucine117 are conserved
based on the critical amino acids of the BH3 domain of
BAK that determines BAK-Bcl-XL heterodimerization (31).
Other BH3 domain-only Bcl-2 family members that are
death agonists have been described such as Bik/Nbk (32,
33), Bid (34) and, more recently, Hrk (35). Bik and Hrk
have putative transmembrane domains while Bid is a cyto-
plasmic factor that is hypothesized to be recruited to mem-
brane-associated Bcl-2 or Bax. Thus it is possible that Nip3
is a death factor of the Bcl-2 family related to Bik/Nbk,
Bid, or Hrk.
Many Bcl-2 family members are integral membrane pro-
teins that bear COOH-terminal regions that allow localiza-
tion to the mitochondrial outer membrane, nuclear enve-
lope and endoplasmic reticulum (15, 36, 37). Localization
of Bcl-2 to mitochondria also appears to be important in its
suppression of cell death as mutants lacking the transmem-
brane domain are ineffective when overexpressed (14, 38).
Nip3 shares the ability to localize to mitochondria and re-
cent work suggests that mitochondria may play an impor-
tant role in the regulation of apoptosis. They are necessary
for the apoptotic activity of cytosolic extracts of Xenopus laevis
oocytes (39), and can initiate nuclear destruction when
taken from cells undergoing apoptosis in in vitro reconsti-
tuted cell systems (16). Nip3 localization in mitochondria
places it in a position to influence mitochondrial function
early in the apoptotic response. Nip3 can overcome Bcl-2
suppression of apoptosis so it might act on Bcl-2 or other
anti-apoptotic family members that regulate mitochondrial
permeability transition pores (16, 17) or cytochrome c re-
lease (18–20). Nip3 preferentially forms homodimers even
under reducing conditions and could provide a stable link
between Bcl-2 homo- and/or heterodimers and other pro-
teins perhaps forming larger complexes or altering their in-
teraction with regulators such as BAD (30).
In conclusion, we have identified the E1B 19K/Bcl-2
binding protein Nip3 as a homodimer localized to mito-
chondrial membrane. Nip3 expression in mitochondria in-
duces apoptosis and can overcome Bcl-2 suppression of cell
death, indicating that Nip3 is a novel pro-apoptotic pro-
tein.
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